Recordati, IT0003828271

CVC raises bid for Recordati stock and plans a delisting

Published on 10/07/2026 at 09:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVC lifted the offer to EUR 53.00 on October 6, 2026. Recordati stock costs EUR 53.03 on October 7, 2026 after EUR 52.84, plus 0.36 percent.

Flatlay mit Aktienzertifikat, ISIN-Karte, Tabletten und Stethoskop auf Holztisch
Recordati S.p.A. (IT0003828271) symbolisiert dieses Flatlay mit Aktienzertifikat, ISIN-Karte und typischen Pharma-Utensilien, Illustration mit AI erstellt.

CVC Capital Partners and Groupe Bruxelles Lambert raised their cash offer for Recordati (IT0003828271) from EUR 51.29 to EUR 53.00 per share on October 6, 2026. As Reuters reports, the consortium called the revised price its best and final offer and extended the acceptance period to October 23, 2026.

Offer price moves to EUR 53

The new bid is 3.34 percent above the previous EUR 51.29 offer, calculated against the original bid. The revised consideration also includes EUR 0.71 from Recordati's 2025 dividend, bringing the total value to EUR 53.71 per share, according to Investing.com on October 6, 2026.

The tender process had attracted shareholders representing 49.79 percent of Recordati's share capital by October 5, 2026, while CVC already held 46.80 percent, Reuters reported on October 6, 2026. Payment for shares tendered during the extended period is scheduled for November 2, 2026.

Operating figures support the bid

The takeover unfolds against a solid first-half operating backdrop. In its H1 2026 earnings call, Recordati reported revenue of EUR 1.4 billion, up 6.60 percent year over year, while EBITDA rose 8.80 percent to EUR 540.20 million, according to Yahoo Finance.

Rare disease revenue increased 17.10 percent to EUR 604.00 million in the first half of 2026, providing the strongest quantified growth contribution in the reported period. Recordati also confirmed full-year 2026 targets of EUR 2.73 billion to EUR 2.80 billion in net revenue and EUR 995.00 million to EUR 1.03 billion in EBITDA.

Recordati stock stays near the bid

Recordati stock was trading at EUR 53.03 at Lang & Schwarz on October 7, 2026 at 9:03 a.m. CEST, up 0.36 percent versus the EUR 52.84 prior close at Lang & Schwarz on October 6, 2026. The quote is EUR 0.03 above the revised cash offer, showing how closely the market price is tracking the bid while the acceptance period remains open. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.

Recordati stock at a glance

  • Company: Recordati Industria Chimica e Farmaceutica S.p.A.
  • ISIN: IT0003828271
  • WKN: A0EABR
  • Ticker: RER1
  • Primary exchange: Euronext Milan
  • Price Lang & Schwarz (as of October 7, 2026, 9:03 a.m. CEST): EUR 53.03
  • Change versus prior close: plus 0.36 percent
  • Prior close Lang & Schwarz (October 6, 2026): EUR 52.84
  • Sector / Industry: Pharmaceuticals

More news and analyses on Recordati stock

Disclaimer...

en | IT0003828271 | RECORDATI | boerse | 70252900 | bgmi